[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 6, Issue 2 (9-2017) ::
پرستاری قلب و عروق 2017, 6(2): 66-73 Back to browse issues page
Drug updates for prevention and treatment of venous thromboembolism in orthopedic surgeries
Anolin Aslan1 , Roya Khorami1 , Jalal Rezaii1 , Mohammad Godarzi1 , Zahra Abbasi Dolatabadi * 2
1- School of Nursing and Midwifery, Tehran University of Medical Science, Tehran, Iran
2- Department of Critical Care Nursing, School of Nursing and Midwifery, Tehran University of Medical Science, Tehran, Iran , zahra_abasi2000@yahoo.com
Abstract:   (7184 Views)
Abstract
Aim. The purpose of this study is to review new achievements in prevention and treatment of venous thromboembolism (VTE) in orthopedic surgeries.
Background.
Method. This is a comprehensive review of literature published between 1998-2017 about prevention and treatment of VTE in orthopedic surgeries that was conducted through searching scientific databases and search engines Ovid, Science Direct, Medline, Google Scholar, and PubMed using the English and Persian forms of the words Apixaban, Dabigatran, Heparin, orthopedic procedures, venous thromboembolism, and Fondaparinux. In total, 35 English papers and 10 Persian papers were found, out of which 25 papers were included in the review.
Findings. The risk of VTE is increased considerably during orthopedic surgeries. It is associated with important morbidities and also can increase mortality rate. Without prophylaxis, there is a noticeably increased risk of both venous and pulmonary embolism. Choosing a prophylactic pharmacologic agent depends on its efficacy and safety and also, on the presence of comorbidities and patient preferences.
Conclusion. The features of primary preferred primary prophylactic method is easy management safety, effectiveness with limited or no need for laboratory observation, and cost effectiveness. The use of prophylactic anticoagulation in patient undergoing major orthopedic surgeries considerably reduces the risk of VTE, but does not completely exclude it.
Keywords: Venous Thromboembolism, Orthopedic surgeries, Prophylactic anticoagulation
Full-Text [PDF 914 kb]   (24178 Downloads)    
: Applicable | Subject: Clinical nurses knowledge resources
Received: 2018/05/17 | Accepted: 2018/08/29 | Published: 2017/09/15 | ePublished: 2017/09/15
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aslan A, Khorami R, Rezaii J, Godarzi M, Abbasi Dolatabadi Z. Drug updates for prevention and treatment of venous thromboembolism in orthopedic surgeries. پرستاری قلب و عروق 2017; 6 (2) :66-73
URL: http://journal.icns.org.ir/article-1-495-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6, Issue 2 (9-2017) Back to browse issues page
فصلنامه پرستاری قلب و عروق Iranian Journal of Cardiovascular Nursing
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4660